Sanifoam Valuation Multiples

Sanifoam is valued at $31M as of November 2026, a 1.8x revenue multiple. In the last fiscal year, Sanifoam revenue was $23M and Sanifoam EBITDA was $2M.

Sanifoam Overview

About Sanifoam

Sanifoam Endustri Ve Tuketim Urunleri Sanayi Ticaret AS, formerly Sanifoam Sunger Sanayi ve Ticaret AS is engaged in manufacturing of technical foams and cleaning supplies. Its products include cleaning towels, scouring sponges, bath sponges, heat insulation products, filter polishing and sealing foams.


Founded

1990

HQ

Turkey

Employees

257

Financials (Last FY)

Revenue: $23M
EBITDA: $2M

EV

$42M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sanifoam Financials

Sanifoam reported last fiscal year revenue of $23M and EBITDA of $2M.

In the same fiscal year, Sanifoam generated $5M in gross profit, $2M in EBITDA, and $36K in net income.


Sanifoam P&L

In the most recent fiscal year, Sanifoam reported revenue of $23M and EBITDA of $2M.

Sanifoam is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 10%, and net margin of 0%.

See analyst estimates for Sanifoam
Last FY2025202620272028
Revenue$23M$23M
Gross Profit$5M$5M
Gross Margin23%23%
EBITDA$2M$2M
EBITDA Margin10%10%
EBIT Margin12%12%
Net Profit$36K$36K
Net Margin0%0%
Net Debt$7M-

Financial data powered by Morningstar, Inc.

Sanifoam Stock Performance

Sanifoam has current market cap of $31M, and enterprise value of $42M.

Market Cap Evolution


Sanifoam's stock price is $0.08.

Sanifoam share price increased by 23.4% in the last 30 days, and decreased by 43.5% in the last year.

See more trading valuation data for Sanifoam
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$42M$31M6.5%23.4%-61.5%-43.5%$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sanifoam Valuation Multiples

Sanifoam trades at 1.8x EV/Revenue multiple, and 18.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Sanifoam

Sanifoam Financial Valuation Multiples

As of November 7, 2026, Sanifoam has market cap of $31M and EV of $42M.

Sanifoam has a P/E ratio of 860.0x.

Last FY2025202620272028
EV/Revenue1.8x1.8x
EV/EBITDA18.6x18.6x
EV/EBIT15.6x15.6x
EV/Gross Profit7.9x7.9x
P/En/mn/m
EV/FCF(7.1x)(7.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sanifoam Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sanifoam Margins & Growth Rates

In the most recent fiscal year, Sanifoam reported gross margin of 23%, EBITDA margin of 10%, and net margin of 0%.

See estimated margins and future growth rates for Sanifoam

Sanifoam Margins

Last FY2025202720282029
Gross Margin23%23%
EBITDA Margin10%10%
EBIT Margin12%12%
Net Margin0%0%
FCF Margin(26%)(26%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Sanifoam Operational KPIs

Sanifoam's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Sanifoam
Last FY2025202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.0M-
S&M Expenses to Revenue4%4%
G&A Expenses to Revenue2%2%
Opex to Revenue11%11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sanifoam Competitors

Sanifoam competitors include Koroplast, Maghreb Oxygene, Evexia Lifecare, Cropmate, Bergen Carbon Solutions, American Vanguard, Hove, Carbochim, Nexam Chemical Holding and Mercan Kimya.

Most Sanifoam public comparables operate across Chemicals and General Merchandise.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Koroplast$38M$5M0.9x-6.8x-
Maghreb Oxygene------
Evexia Lifecare$12M$305K5.5x-210.8x-
Cropmate$48M$6M0.7x0.7x6.0x6.1x
Bergen Carbon Solutions-($4M)--(4.1x)(4.4x)
American Vanguard$515M($10M)0.5x0.5x(26.9x)6.9x
Hove$31M$3M0.9x0.8x8.7x-
Carbochim$6M$123K3.8x-181.8x-

This data is available for Pro users. Sign up to see all Sanifoam competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sanifoam

When was Sanifoam founded?Sanifoam was founded in 1990.
Where is Sanifoam headquartered?Sanifoam is headquartered in Turkey.
How many employees does Sanifoam have?As of today, Sanifoam has over 257 employees.
Is Sanifoam publicly listed?Yes, Sanifoam is a public company listed on Borsa Istanbul.
What is the stock symbol of Sanifoam?Sanifoam trades under SANFM ticker.
When did Sanifoam go public?Sanifoam went public in 2012.
Who are competitors of Sanifoam?Sanifoam main competitors include Koroplast, Maghreb Oxygene, Evexia Lifecare, Cropmate, Bergen Carbon Solutions, American Vanguard, Hove, Carbochim, Nexam Chemical Holding, Mercan Kimya.
What is the current market cap of Sanifoam?Sanifoam's current market cap is $31M.
What is the current revenue of Sanifoam?Sanifoam's last fiscal year revenue is $23M.
What is the current EV/Revenue multiple of Sanifoam?Current revenue multiple of Sanifoam is 1.8x.
Is Sanifoam profitable?No, Sanifoam is not profitable.
How many companies Sanifoam has acquired to date?Sanifoam hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Sanifoam has invested to date?Sanifoam hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sanifoam

Lists including Sanifoam

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial